Patents/Assignees

PHARSOLN, Inc.

1 patent in portfolio

US11986479utility2024
Combination Drug Products for Treating Patients Suffering from One or More Medical Conditions Caused by Coronavirus Infection, Including by Sars-cov-2, Its Alpha, Beta, Delta, or Omicron Variants and Sub Variants
0 cites